Unbound MEDLINE

[Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors] RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. [Rofo] Journal article

 
Title[Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors]
Author(s)Jung EM, Clevert DA, Rupp N 
InstitutionInstitut für Röntgendiagnostik, Klinikum Passau. jung@fmi.uni-passau.de
SourceRofo 2003 Oct; 175(10):1403-12.
MeSHAged
Albumins
Angiography, Digital Subtraction
Breast Neoplasms
Carcinoma, Hepatocellular
Colorectal Neoplasms
Contrast Media
English Abstract
Female
Fluorocarbons
Follow-Up Studies
Humans
Hyperthermia, Induced
Image Enhancement
Image Processing, Computer-Assisted
Liver
Liver Neoplasms
Male
Middle Aged
Necrosis
Reproducibility of Results
Tomography, Spiral Computed
Ultrasonography, Doppler
Ultrasonography, Interventional
AbstractPURPOSE: To detect vascularization of liver tumors by ultrasound enhanced with Optison and to determine whether increasing necrosis during a percutaneous thermal ablation can be visualized by this method.
MATERIALS AND METHODS: Twenty-two patients with non-resectable malignant liver tumors (9 patients with HCC, 13 patients with metastases) and a total number of 34 lesions underwent percutaneous radiofrequency thermoablation using a needle applicator perfused with a 0.9 % NaCl solution (Electrotome HiTT 106, Berchtold). The tumor size ranged from 2 to 8 cm with an average size of 3.6 cm. While intermittent energy was supplied during thermoablation, multi-slice CT (Volume-Zoom, Siemens) and ultrasound were obtained. Ultrasound was performed with a multi-frequency transducer (3 - 7 MHz, LOGIQ 700, GE) and 0.5 to 1 ml of Optison as contrast agent. If necessary, the injection of the contrast agent was repeated after about 30 min. The mechanical index (MI) was set low (0.2 - 0.3) to prevent bubble destruction. Ultrasound power Doppler (PD), contrast harmonic imaging (CHI) and coded harmonic angiography (CHA) as subtraction mode of harmonic imaging were applied intermittently.
RESULTS: Only 21 of the 34 lesions showed increased intratumoral perfusion when the conventional B-Mode with PD was used. Similar to spiral CT, the tumor vascularization in the early arterial phase was only reliably visible with CHA after application of contrast agent. CHI with PD was best to detect increasing hypoperfusion of the tumors. When the energy supply was continued, hyperechoic border zones became visible around the central hypoechoic defects. The contrast between remaining tumor and surrounding liver tissue improved in CHI for up to 30 min after the bolus injection of contrast medium, considerably facilitating the evaluation of perfusion. Metal artifacts and the limited amount of contrast agent that can be safely administered interfered with monitoring the thermal ablation with spiral-CT. After an administered energy of maximal 100.000 watts, no more tumor vascularization was seen in 28 of 34 cases. Follow-up spiral-CT showed a complete necrosis in these cases.
CONCLUSION: Evaluating perfusion with contrast-enhanced ultrasound may be helpful in monitoring the evolving necrosis during thermoablation of liver tumors. The more reliable assessment of the tumor necrosis enables a more targeted therapy.
Languageger
Pub Type(s)Journal Article
PubMed ID14556110
  
Advertise on this site.